Aveo Pharmaceuticals

Aveo's Inflection Point: Tivozanib Likely To Receive Positive Advisory Vote, FDA Approval
Seeking Alpha
Wed, 04/24/13 - 10:19 am
Aveo Pharmaceuticals
FDA
tivozanib
GSK
Onyx
Pfizer
renal cell carcinoma
Roche

Pages